ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

CDXS Codexis Inc

3.95
0.61 (18.26%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Codexis Inc CDXS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.61 18.26% 3.95 13:00:14
始値 安値 高値 終値 前日終値
3.62 3.53 4.01 3.92 3.34
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0305:05GLOBECodexis Reports First Quarter 2024 Financial Results
2024/4/1905:05GLOBECodexis to Report First Quarter 2024 Financial Results on..
2024/4/1120:05GLOBECodexis Appoints Carole Cobb, MBA, to Strategic Advisory..
2024/3/0706:02EDGAR2Form 8-K - Current report
2024/2/2906:05GLOBECodexis Reports Fourth Quarter and Fiscal Year 2023..
2024/2/2802:15APSBiotech Rallied Strongly On Exclusive Licensing Agreement
2024/2/2706:05GLOBECodexis Enters Exclusive Licensing Agreement for Newly..
2024/2/2622:05GLOBECodexis to Participate in TD Cowen 44th Annual Health Care..
2024/2/2022:05GLOBECodexis Announces Appointment of Masad Damha, PhD, and Jim..
2024/2/1706:01EDGAR2Form 8-K - Current report
2024/2/1506:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:05GLOBECodexis to Report Fourth Quarter and Fiscal Year 2023..
2024/2/1406:19EDGAR2Form 8-K - Current report
2024/2/1406:05GLOBECodexis Secures $40 Million in Strategic Financing Deal with..
2024/2/1006:06EDGAR2Form 8-K - Current report
2024/2/0206:05GLOBEseqWell and Codexis to Unveil Engineered Transposase Enzyme..
2024/1/2504:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0922:30EDGAR2Form 8-K - Current report
2024/1/0311:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0311:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0311:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0311:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2722:30GLOBECodexis Announces Purchase Agreement with Nestlé Health..
2023/12/2722:30EDGAR2Form 8-K - Current report
2023/12/1406:06GLOBECodexis and Aldevron Enter Exclusive Licensing Agreement for..
2023/12/1406:05GLOBECodexis Announces Achievement of Gram-scale Synthesis with..
2023/12/1121:05GLOBECodexis KOL Event Highlights Significant Need for an..
2023/11/2906:05GLOBECodexis to Host Virtual KOL Event on its ECO Synthesis™..
2023/11/1807:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1607:31EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1506:05GLOBECodexis to Participate in 35th Annual Piper Sandler..
2023/11/0405:26EDGAR2Form 8-K/A - Current report: [Amend]
2023/11/0405:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0305:16EDGAR2Form 8-K - Current report
2023/11/0305:05GLOBECodexis Reports Third Quarter 2023 Financial Results
2023/11/0105:05GLOBECodexis to Participate in Upcoming Healthcare Conferences
2023/10/2804:35GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
2023/10/2705:05GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
2023/10/2005:05GLOBECodexis to Report Third Quarter 2023 Financial Results on..
2023/9/2920:05GLOBECodexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton..
2023/9/2305:32EDGAR2Form 8-K - Current report
2023/9/1905:05GLOBECodexis CEO Stephen Dilly Named as Finalist of 2023 Bloom..
2023/9/1305:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1305:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1305:05GLOBECodexis to Participate in Cantor Global Healthcare..
2023/9/0805:05EDGAR2Form 8-K - Current report
2023/9/0805:05GLOBECodexis Announces Agreement for Assignment and Assumption of..
2023/8/0405:54EDGAR2Form S-8 - Securities to be offered to employees in employee..

最近閲覧した銘柄

Delayed Upgrade Clock